Dimensional Fund Advisors
CSBR icon

Dimensional Fund Advisors’s Champions Oncology CSBR Stock Holding History

Dimensional Fund Advisors’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,973
Closed -$138K – 3242
2026
Q1 		$138K Sell
23,973
-1,381
-5% -$8.77K ﹤0.01% 3097
2025
Q4 		$175K Buy
25,354
+1,652
+7% +$11K ﹤0.01% 3101
2025
Q3 		$153K Buy
23,702
+1,297
+6% +$9.14K ﹤0.01% 3153
2025
Q2 		$165K Buy
+22,405
New +$158K ﹤0.01% 3138
2024
Q1 		– Sell
-26,839
Closed -$145K – 3399
2023
Q4 		$145K Sell
26,839
-32,241
-55% -$180K ﹤0.01% 3242
2023
Q3 		$367K Sell
59,080
-28,591
-33% -$181K ﹤0.01% 3106
2023
Q2 		$551K Sell
87,671
-28,620
-25% -$148K ﹤0.01% 3043
2023
Q1 		$467K Buy
+116,291
New +$497K ﹤0.01% 3042
2022
Q3 		$914K Buy
121,805
+8,462
+7% +$70.8K ﹤0.01% 2901
2022
Q2 		$917K Buy
113,343
+1,424
+1% +$10.9K ﹤0.01% 2934
2022
Q1 		$910K Buy
111,919
+1,300
+1% +$10.4K ﹤0.01% 3016
2021
Q4 		$885K Sell
110,619
-9,283
-8% -$85.5K ﹤0.01% 3056
2021
Q3 		$1.22M Sell
119,902
-10,753
-8% -$109K ﹤0.01% 2998
2021
Q2 		$1.34M Buy
130,655
+2,362
+2% +$23.9K ﹤0.01% 2968
2021
Q1 		$1.45M Sell
128,293
-3,220
-2% -$37.4K ﹤0.01% 2929
2020
Q4 		$1.42M Sell
131,513
-956
-0.7% -$9.86K ﹤0.01% 2899
2020
Q3 		$1.23M Sell
132,469
-1,200
-0.9% -$10.7K ﹤0.01% 2878
2020
Q2 		$1.28M Buy
133,669
+416
+0.3% +$3.55K ﹤0.01% 2875
2020
Q1 		$986K Hold
133,253
– – ﹤0.01% 2895
2019
Q4 		$1.11M Sell
133,253
-22,245
-14% -$137K ﹤0.01% 2989
2019
Q3 		$879K Hold
155,498
– – ﹤0.01% 3034
2019
Q2 		$1.22M Buy
155,498
+22,328
+17% +$196K ﹤0.01% 3015
2019
Q1 		$1.3M Buy
133,170
+63,727
+92% +$635K ﹤0.01% 2978
2018
Q4 		$542K Buy
+69,443
New +$798K ﹤0.01% 3131

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors's CSBR Position: Q2 2026 in Review

Dimensional Fund Advisors sold out of Champions Oncology (CSBR) in Q2 2026, closing a stake of 23,973 shares — an estimated $138K sold.

Dimensional Fund Advisors first reported a position in CSBR in Q4 2018 and held it in 24 quarters. The position peaked at $1.45M in Q1 2021. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Dimensional Fund Advisors reported no remaining Champions Oncology position as of Q2 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 23,973 Champions Oncology shares in Q2 2026, an estimated $138K.
  • Dimensional Fund Advisors first reported a position in Champions Oncology in Q4 2018 and held it in 24 quarters.
  • Dimensional Fund Advisors's Champions Oncology position peaked at $1.45M in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.